Clinical Trials Logo

Clinical Trial Summary

We are evaluating the effect of methylene blue and visible light activation on the microbiome of the skin.


Clinical Trial Description

Antiseptics are routinely utilized to prevent infections of vascular catheters. We are evaluating the addition of methylene blue and light activation on skin to determine whether this inexpensive and non-toxic treatment can decrease skin pathogens and prevent blood stream infections of long-term vascular catheters. This is a pilot study of normal volunteers to determine the effect on the microbiome of the addition of methylene blue and light activation on antiseptic-treated skin. ;


Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01981460
Study type Interventional
Source Massachusetts General Hospital
Contact
Status Completed
Phase N/A
Start date May 2013
Completion date July 2013

See also
  Status Clinical Trial Phase
Completed NCT03363529 - ROOM-LIGHT: Dynamic LED-light as Treatment for Depressed Patients in Inpatient Wards N/A
Completed NCT05009693 - Effect of White Light on Fatigue Levels in Patients With Gynecological Cancer N/A
Recruiting NCT04155619 - Using Early Time Restricted Feeding and Timed Light Therapy to Improve Glycemic Control in Adults With Type 2 Diabetes N/A